| NDC Code | 0006-4305-02 |
|---|
| Package Description | 1 VIAL in 1 CARTON (0006-4305-02) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0006-4305-01) |
|---|
| Product NDC | 0006-4305 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Renflexis |
|---|
| Non-Proprietary Name | Infliximab |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20170701 |
|---|
| Marketing Category Name | BLA |
|---|
| Application Number | BLA761054 |
|---|
| Manufacturer | Merck Sharp & Dohme LLC |
|---|
| Substance Name | INFLIXIMAB |
|---|
| Strength | 100 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA] |
|---|